In January–February 2026, the Russian retail market for blood pressure monitors (including e-commerce and the FMCG segment) reached RUB 2.53 billion (at retail prices, including VAT). The ruble growth rate compared to the same period in 2025 was recorded at 10.7%. At the same time, physical consumption of these devices decreased by 2%. In the first two months of this year, nearly 1.16 million blood pressure monitors were sold in Russian retail. For the full year 2025, Russians purchased over 6.86 million devices worth more than RUB 13.8 billion, but the growth dynamics were more moderate, both in rubles (+5%) and in physical units (+1.4%). In the previous two years, the category had shown double-digit sales growth rates. The growth driver is primarily the online channel: in 2025, growth dynamics here were recorded at 16.5% in rubles, and in 2024 they exceeded 41%, while demand in traditional retail outlets remained almost unchanged. As a result, the share of online sales in this medical device category reached 48.5% of total physical volume and 33.7% of ruble volume in 2025.

According to the "Retail Audit of Medical Device Sales in Russia (total sell out)" from the analytical company RNC Pharma, demand for these devices increased in March of last year, followed by a summer lull — the minimum demand was recorded in June, when Russians purchased only 481,000 devices, spending RUB 954 million. In autumn, interest in blood pressure monitors began to recover. The maximum retail sales volume is annually recorded in December — in 2025, nearly 659,000 devices worth RUB 1.42 billion were sold in our country during that month. At the beginning of 2026, after a January pause, the market returned to growth — in February, 600,000 devices worth RUB 1.3 billion were sold.

In 2025, the retail blood pressure monitor market included 75 brands. Over the past two years, more than 20 new products have been introduced in the category, mostly of Chinese origin. The most significant sales share among new products belongs to the automatic blood pressure monitor 4Fokea (from Wuxi Exanovo), with brand sales increasing 98-fold in rubles over the year, allowing it to enter the top twenty leading brands. Nevertheless, the blood pressure monitor market remains highly concentrated, with the top three brands accounting for 72% of all sales in monetary terms. Leadership in the category is retained by products of the Japanese brand Omron with a 29.5% market share in rubles, closely followed by devices from A&D (28.1%) in second place. Rounding out the top three is the Swiss company B.Well (14.5%).

Fig. Monthly Sales Volume of Blood Pressure Monitors on the Russian Retail Market (including marketplaces and the FMCG channel) for the Period from December 2024 to February 2026